Sanofi files appeal in case against Mylan over Epipen
June 03, 2021 at 12:34 PM EDT
Sanofi claimed Mylan, based in Canonsburg, had been anticompetitive in marketing EpiPen to the detriment of Auvi-Q and Sanofi.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|